Bridgeway Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Buy |
460,273
+31,744
| +7% | +$759K | 0.26% | 110 |
|
|
2025
Q1 | $10.6M | Buy |
428,529
+69,744
| +19% | +$1.73M | 0.27% | 108 |
|
|
2024
Q4 | $6.76M | Buy |
358,785
+11,149
| +3% | +$210K | 0.15% | 201 |
|
|
2024
Q3 | $5.23M | Buy |
+347,636
| New | +$5.23M | 0.11% | 266 |
|
|
2021
Q4 | – | Sell |
-8,300
| Closed | -$465K | – | 1316 |
|
|
2021
Q3 | $465K | Buy |
+8,300
| New | +$465K | 0.01% | 1056 |
|